BiondVax Pharmaceuticals Balance Sheet Statement

BVXV $4.62 0.3 6.3%

5:02pm

Speculative, Micro Cap, Sucker Stock

Market Cap £35.5m

Enterprise Value £44.5m

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock BiondVax Pharmaceuticals's balance sheet statement please upgrade your membership.

	2014	2015	2016	2017	2018	2019
Period End:	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31
Period Length:	0	0	0	0	0	0
Currency:	ILS	ILS	ILS	ILS	ILS	ILS

Cash & Equivalents
Short Term Investments
Cash and Short Term Investments
Total Receivables, Net
Total Current Assets

Property/Plant/Equipment, Total - Net
Long Term Investments
Other Long Term Assets, Total
Total Assets

Accounts Payable
Payable/Accrued
Notes Payable/Short Term Debt
Current Port. of LT Debt/Capital Leases
Total Current Liabilities

Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Other Liabilities, Total
Total Liabilities

Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.